Envoy Medical (COCHW) Cost of Revenue (2022 - 2026)

Envoy Medical has disclosed Cost of Revenue across 5 years of filings, most recently posting $313000.0 for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $313000.0, up 38.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (up 134.68% YoY), and the FY2025 annual result was $1.2 million, up 64.42% from the prior year.
• Cost of Revenue came in at $313000.0 for Q1 2026 at Envoy Medical, down from $557000.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $557000.0 in Q4 2025 to a low of -$474000.0 in Q4 2024.
• The 5-year median for Cost of Revenue is $313000.0 (2026), against an average of $279866.7.
• Across the five-year window, Cost of Revenue soared 276.42% in 2023 and tumbled 192.4% in 2024, its largest moves.
• Envoy Medical's Cost of Revenue stood at $538000.0 in 2022, then retreated by 4.65% to $513000.0 in 2023, then sank by 192.4% to -$474000.0 in 2024, then surged by 217.51% to $557000.0 in 2025, then slumped by 43.81% to $313000.0 in 2026.
• The last three Cost of Revenue figures came in at $313000.0 (Q1 2026), $557000.0 (Q4 2025), and $405000.0 (Q3 2025), per Business Quant data.